COVID 19 VA FARMATSEVTIKANING ROLI
Keywords:
COVID-19, farmatsevtika sanoati, vaksina ishlab chiqarish, pandemiya, klinik tadqiqotlar, dori-darmon ta’minoti, global hamkorlik, innovatsiyalar.Abstract
Ushbu maqolada COVID-19 pandemiyasining farmatsevtika sanoatiga ta'siri o'rganiladi. Pandemiya jarayonida dori vositalari va vaksinlar ishlab chiqishdagi qiyinchiliklar, klinik sinovlar, innovatsion texnologiyalar va global hamkorlik masalalari ko'rib chiqiladi. Shu bilan birga, pandemiya farmatsevtika kompaniyalariga qanday chaqiriqlar yaratgani va ular qaysi imkoniyatlardan foydalanib, sog'liqni saqlash tizimiga yordam bergani tahlil qilinadi.
References
1. World Health Organization (WHO). (2020). "Draft landscape of COVID-19 candidate vaccines." Retrieved from https://www.who.int
2. Centers for Disease Control and Prevention (CDC). (2021). "COVID-19 Vaccination: A Key Tool to End the Pandemic." Retrieved from https://www.cdc.gov.
3. Polack, F. P., et al. (2020). "Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine." The New England Journal of Medicine, 383(27), 2603-2615.
4. Baden, L. R., et al. (2021). "Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine." The New England Journal of Medicine, 384(5), 403-416.
5. Wouters, O. J., et al. (2021). "Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment." The Lancet, 397(10278), 1023-1034.
6. Mahase, E. (2020). "Covid-19: What have we learnt about the virus and its management?" BMJ, 370.
7. Dyer, O. (2021). "Covid-19: Vaccine distribution must help all countries, says WHO." BMJ, 372.
8. Amanat, F., & Krammer, F. (2020). "SARS-CoV-2 vaccines: status report." Immunity, 52(4), 583-589.
9. Graham, B. S. (2020). "Rapid COVID-19 vaccine development." Science, 368(6494), 945-946.
10. Krammer, F. (2020). "SARS-CoV-2 vaccines in development." Nature, 586(7830), 516-527.
